foscarnet has been researched along with Herpes Zoster in 40 studies
Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.
Herpes Zoster: An acute infectious, usually self-limited, disease believed to represent activation of latent varicella-zoster virus (HERPESVIRUS 3, HUMAN) in those who have been rendered partially immune after a previous attack of CHICKENPOX. It involves the SENSORY GANGLIA and their areas of innervation and is characterized by severe neuralgic pain along the distribution of the affected nerve and crops of clustered vesicles over the area. (From Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Persons with AIDS who have CD4+ counts < or = 100 and transplant patients, especially bone marrow allograft recipients, may experience clinically significant infections with acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV)." | 8.79 | Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. ( Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S, 1994) |
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 7.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| "To report of a case of acute retinal necrosis (ARN), successfully treated with intravitreal foscarnet." | 7.77 | Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus. ( Kim, KS; Lee, MY; Lee, WK, 2011) |
| "Persons with AIDS who have CD4+ counts < or = 100 and transplant patients, especially bone marrow allograft recipients, may experience clinically significant infections with acyclovir-resistant herpes simplex virus (HSV) or varicella-zoster virus (VZV)." | 4.79 | Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. ( Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S, 1994) |
| " We report successful BCV use in management of disseminated acyclovir- and cidofovir-resistant varicella zoster virus in an immunocompromised hematopoietic stem cell transplant patient with chronic graft-versus-host disease who was intolerant to foscarnet." | 3.83 | Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host. ( Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J, 2016) |
| " Herpes simplex virus (HSV) reactivations are usually prevented by acyclovir (ACV) prophylaxis, whereas cidofovir (CDV) has been used off indication to manage AdV infections." | 3.83 | Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation. ( Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S, 2016) |
| "To report of a case of acute retinal necrosis (ARN), successfully treated with intravitreal foscarnet." | 3.77 | Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus. ( Kim, KS; Lee, MY; Lee, WK, 2011) |
| " Three months later he developed herpes zoster, which developed into chronic verrucous lesions that were refractory to treatment with acyclovir and which subsequently disseminated." | 3.72 | Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. ( Dahl, KM; Giller, R; Krause, PR; Levin, MJ; Patel, A; Weinberg, A, 2003) |
| "Seventeen AIDS patients with cytomegalovirus (CMV), herpes simplex virus (HSV), varicella-zoster virus (VZV) infection, Kaposi's sarcoma (KS), or a combination of these were treated with foscarnet." | 3.70 | Foscarnet decreases HIV-1 plasma load. ( Barbeau, P; Breilh, D; Denisi, R; Devianne-Garrigue, I; Dupon, M; Fleury, HJ; Leng, B; Pellegrin, I; Pellegrin, JL; Ragnaud, JM, 1998) |
| "We describe a 28-year-old HIV-infected woman with AIDS, defined by cerebral toxoplasmosis and a CD4-count of less than 10 x 10(6) cells/I, who, after several eruptions of genital herpes and typical dermatomal herpes zoster, all successfully treated with acyclovir, developed chronic cutaneous ulcerating lesions on a finger and on the tibia." | 3.69 | Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient. ( Bernhard, P; Obel, N, 1995) |
| "To determine whether foscarnet has potential efficacy in the treatment of acyclovir-resistant mucocutaneous varicella-zoster infection in patients with the acquired immunodeficiency syndrome (AIDS)." | 3.68 | Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. ( Berger, TG; Biron, KK; Gilson, I; Mills, J; Safrin, S; Wofsy, CB; Wolfe, PR, 1991) |
| " These questions concern appropriate routes of administration for antiviral compounds, optimal dosage regimens, risks of long-term prophylaxis, and the emergence of resistant organisms." | 2.66 | Antiviral chemotherapy and chemoprophylaxis. ( Dolin, R, 1985) |
| "The first is the acute retinal necrosis syndrome, which also may be seen in immunocompetent hosts." | 2.41 | Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS. ( Bellehemeur, T; DiazGranados, C; Franco-Paredes, C; Merchant, A; Rimland, D; Sanghi, P, 2002) |
| "Acyclovir is a prototype of this improved process." | 2.37 | Promising new antiviral drugs. ( Bryson, YJ, 1988) |
| "The alphaherpesvirus varicella-zoster virus (VZV) causes chickenpox and shingles." | 1.40 | β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism. ( Arnold, RD; Chavre, S; Chu, CK; De, C; Hagen, FK; Liu, D; Moffat, JF; Singh, US; White, C; Zheng, B, 2014) |
| "We report a 34-year-old woman with acute lymphoblastic leukemia underwent allogenic bone marrow transplant (BMT)." | 1.31 | Giant cell lichenoid dermatitis within herpes zoster scars in a bone marrow recipient. ( Bartolomé, B; Córdoba, S; Fernández-Herrera, J; Fraga, J; García-Díez, A, 2000) |
| " The use of oral acyclovir preparations with higher bioavailability (valacyclovir) or intravenous acyclovir early on may prevent the considerable morbidity associated with disseminated zoster infection." | 1.31 | Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient. ( Mahendra, P; Osman, H; Tauro, S; Toh, V, 2000) |
| " The dosage of Foscarnet was increased during the study." | 1.27 | Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation. ( Ahlmén, J; Brynger, H; Lycke, E; Wijnween, AC, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.50) | 18.7374 |
| 1990's | 19 (47.50) | 18.2507 |
| 2000's | 10 (25.00) | 29.6817 |
| 2010's | 8 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schnute, ME | 1 |
| Anderson, DJ | 1 |
| Brideau, RJ | 1 |
| Ciske, FL | 1 |
| Collier, SA | 1 |
| Cudahy, MM | 1 |
| Eggen, M | 1 |
| Genin, MJ | 1 |
| Hopkins, TA | 1 |
| Judge, TM | 1 |
| Kim, EJ | 1 |
| Knechtel, ML | 1 |
| Nair, SK | 1 |
| Nieman, JA | 1 |
| Oien, NL | 1 |
| Scott, A | 1 |
| Tanis, SP | 1 |
| Vaillancourt, VA | 1 |
| Wathen, MW | 1 |
| Wieber, JL | 1 |
| Wong, KJ | 1 |
| Osowicki, J | 1 |
| Seaby, E | 1 |
| Curtis, N | 1 |
| Gwee, A | 1 |
| De, C | 1 |
| Liu, D | 1 |
| Zheng, B | 1 |
| Singh, US | 1 |
| Chavre, S | 1 |
| White, C | 1 |
| Arnold, RD | 1 |
| Hagen, FK | 1 |
| Chu, CK | 1 |
| Moffat, JF | 1 |
| Mullane, KM | 1 |
| Nuss, C | 1 |
| Ridgeway, J | 1 |
| Prichard, MN | 1 |
| Hartline, CB | 1 |
| Theusch, J | 1 |
| Mommeja-Marin, H | 1 |
| Larson, RA | 1 |
| Voigt, S | 1 |
| Hofmann, J | 1 |
| Edelmann, A | 1 |
| Sauerbrei, A | 1 |
| Kühl, JS | 1 |
| Shimizu, R | 1 |
| Ohwada, C | 1 |
| Nagao, Y | 1 |
| Togasaki, E | 1 |
| Kawajiri, C | 1 |
| Muto, T | 1 |
| Tsukamoto, S | 1 |
| Sakai, S | 1 |
| Takeda, Y | 1 |
| Mimura, N | 1 |
| Takeuchi, M | 1 |
| Sakaida, E | 1 |
| Iseki, T | 1 |
| Nakaseko, C | 1 |
| Meghpara, B | 1 |
| Sulkowski, G | 1 |
| Kesen, MR | 1 |
| Tessler, HH | 1 |
| Goldstein, DA | 1 |
| Bleymehl, K | 1 |
| Cinatl, J | 1 |
| Schmidt-Chanasit, J | 1 |
| Lee, MY | 1 |
| Kim, KS | 1 |
| Lee, WK | 1 |
| Aoyama, Y | 1 |
| Yamamura, R | 1 |
| Shima, E | 1 |
| Nakamae, H | 1 |
| Makita, K | 1 |
| Hasegawa, T | 1 |
| Sakamoto, C | 1 |
| Terada, Y | 1 |
| Kho, G | 1 |
| Ohta, K | 1 |
| Yamane, T | 1 |
| Takubo, T | 1 |
| Hino, M | 1 |
| Levin, MJ | 1 |
| Dahl, KM | 1 |
| Weinberg, A | 1 |
| Giller, R | 1 |
| Patel, A | 1 |
| Krause, PR | 1 |
| Ramos, C | 1 |
| Lajusticia, J | 1 |
| Nakamoto, BK | 1 |
| Dorotheo, EU | 1 |
| Biousse, V | 1 |
| Tang, RA | 1 |
| Schiffman, JS | 1 |
| Newman, NJ | 1 |
| Tan, HH | 1 |
| Goh, CL | 1 |
| Angarone, M | 1 |
| Ison, MG | 1 |
| Bendel, AE | 1 |
| Gross, TG | 1 |
| Woods, WG | 1 |
| Edelman, CK | 1 |
| Balfour, HH | 2 |
| Benson, C | 1 |
| Braun, J | 1 |
| Cassens, B | 1 |
| Erice, A | 1 |
| Friedman-Kien, A | 1 |
| Klein, T | 1 |
| Polsky, B | 1 |
| Safrin, S | 2 |
| Ricart Olmos, C | 1 |
| López Aldeguer, J | 1 |
| Marino Blanes Juliá, F | 1 |
| Sinelni, E | 1 |
| Fillet, AM | 4 |
| Visse, B | 2 |
| Caumes, E | 2 |
| Dumont, B | 2 |
| Gentilini, M | 1 |
| Huraux, JM | 3 |
| Bernhard, P | 1 |
| Obel, N | 1 |
| Klein, JL | 1 |
| Sandy, C | 1 |
| Migdal, CS | 1 |
| Main, J | 1 |
| Spaide, RF | 1 |
| Martin, DF | 1 |
| Teich, SA | 2 |
| Katz, A | 1 |
| Toth, I | 1 |
| Moorthy, RS | 1 |
| Weinberg, DV | 1 |
| Berger, BB | 1 |
| Minturn, JT | 1 |
| Kumar, S | 1 |
| Rao, NA | 1 |
| Fowell, SM | 1 |
| Loose, IA | 1 |
| Jampol, LM | 1 |
| Meenken, C | 1 |
| van den Horn, GJ | 1 |
| de Smet, MD | 1 |
| van der Meer, JT | 1 |
| Devianne-Garrigue, I | 1 |
| Pellegrin, I | 1 |
| Denisi, R | 1 |
| Dupon, M | 1 |
| Ragnaud, JM | 1 |
| Barbeau, P | 1 |
| Breilh, D | 1 |
| Leng, B | 1 |
| Fleury, HJ | 1 |
| Pellegrin, JL | 1 |
| Lesueur, A | 1 |
| Bouscary, D | 1 |
| Ginsburg, C | 1 |
| Palmer, P | 1 |
| Chaine, B | 1 |
| Salmon-Ceron, D | 1 |
| Dreyfus, F | 1 |
| Sicard, D | 1 |
| Breton, G | 1 |
| Katlama, C | 1 |
| Bricaire, F | 1 |
| Iten, A | 1 |
| Chatelard, P | 1 |
| Vuadens, P | 1 |
| Miklossy, J | 1 |
| Meuli, R | 1 |
| Sahli, R | 1 |
| Meylan, PR | 1 |
| Córdoba, S | 1 |
| Fraga, J | 1 |
| Bartolomé, B | 1 |
| García-Díez, A | 1 |
| Fernández-Herrera, J | 1 |
| Tauro, S | 1 |
| Toh, V | 1 |
| Osman, H | 1 |
| Mahendra, P | 1 |
| Franco-Paredes, C | 1 |
| Bellehemeur, T | 1 |
| Merchant, A | 1 |
| Sanghi, P | 1 |
| DiazGranados, C | 1 |
| Rimland, D | 1 |
| Masur, H | 1 |
| Berger, TG | 1 |
| Gilson, I | 1 |
| Wolfe, PR | 1 |
| Wofsy, CB | 1 |
| Mills, J | 1 |
| Biron, KK | 1 |
| Smith, KJ | 1 |
| Kahlter, DC | 1 |
| Davis, C | 1 |
| James, WD | 1 |
| Skelton, HG | 1 |
| Angritt, P | 1 |
| Moeland, A | 1 |
| Bruun, JN | 1 |
| Bryson, YJ | 1 |
| Dolin, R | 1 |
| Ahlmén, J | 1 |
| Wijnween, AC | 1 |
| Brynger, H | 1 |
| Lycke, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies[NCT00002272] | 0 participants | Interventional | Completed | ||||
| An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies[NCT00002021] | 0 participants | Interventional | Completed | ||||
| A Multi-centered, Randomized Study to Evaluate the Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection Compared to Intravenous Acyclovir in Patients With Herpes Zoster From China[NCT02151240] | Phase 4 | 94 participants (Actual) | Interventional | 2014-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for foscarnet and Herpes Zoster
| Article | Year |
|---|---|
Progressive outer retinal necrosis presenting with isolated optic neuropathy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infection | 2004 |
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Ad | 2006 |
Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
Topics: Antiviral Agents; Benzimidazoles; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Zoster; | 2008 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female | 1994 |
Aseptic meningitis and optic neuritis preceding varicella-zoster progressive outer retinal necrosis in a patient with AIDS.
Topics: Adrenal Cortex Hormones; Adult; AIDS-Related Opportunistic Infections; Anti-Inflammatory Agents; Ant | 2002 |
[Treatment of herpesvirus infections].
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganc | 1991 |
Promising new antiviral drugs.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganc | 1988 |
1 trial available for foscarnet and Herpes Zoster
| Article | Year |
|---|---|
Antiviral chemotherapy and chemoprophylaxis.
Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomega | 1985 |
32 other studies available for foscarnet and Herpes Zoster
| Article | Year |
|---|---|
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibit | 2007 |
Bullous herpes zoster.
Topics: Adolescent; Anti-Bacterial Agents; Antiviral Agents; Arthritis, Juvenile; Female; Floxacillin; Fosca | 2014 |
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chickenpox; Dioxolanes; Drug The | 2014 |
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Re | 2016 |
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Chi | 2016 |
The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
Topics: Acyclovir; Antiviral Agents; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantati | 2017 |
Long-term follow-up of acute retinal necrosis.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; Cytomegalovirus; Cytomegalovirus Infections; Drug | 2010 |
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Bromodeoxyuridine; Cell Line; Drug Resistance, | 2011 |
Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Zoster; Herpesvirus 3, | 2011 |
[Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
Topics: Acyclovir; Adult; Antiviral Agents; Central Nervous System Neoplasms; Drug Resistance, Viral; Foscar | 2003 |
Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
Topics: Abdominal Neoplasms; Acyclovir; Antiviral Agents; Chickenpox Vaccine; DNA, Viral; Drug Resistance, V | 2003 |
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Re | 2004 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
Failure of foscarnet in disseminated herpes zoster.
Topics: Adolescent; Bone Marrow Transplantation; Female; Foscarnet; Herpes Zoster; Humans; Opportunistic Inf | 1993 |
[Herpes zoster during foscarnet treatment in an AIDS patient].
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis | 1993 |
Foscarnet-resistant multidermatomal zoster in a patient with AIDS.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Microbia | 1995 |
Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chronic Disease; Drug Res | 1995 |
Famciclovir in AIDS-related acute retinal necrosis.
Topics: 2-Aminopurine; Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Famciclovir; Foscarnet; | 1996 |
Successful treatment of progressive outer retinal necrosis syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Fundus Oc | 1996 |
Management of varicella zoster virus retinitis in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysi | 1997 |
Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antivir | 1998 |
Foscarnet decreases HIV-1 plasma load.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Femal | 1998 |
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].
Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; HIV Seronegativit | 1998 |
Single amino acid change in DNA polymerase is associated with foscarnet resistance in a varicella-zoster virus strain recovered from a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Amino Acid Substitution; Antivira | 1998 |
Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Res | 1998 |
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System In | 1999 |
Giant cell lichenoid dermatitis within herpes zoster scars in a bone marrow recipient.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Cicatrix; Dermatitis; Female; Fosca | 2000 |
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Encephalitis, Varicella | 2000 |
Clinical implications of herpesvirus infections in patients with AIDS. Introduction.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Cytomegalovirus Infections; Eye Infections, Vi | 1992 |
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cohort Studies; Drug Resista | 1991 |
Acyclovir-resistant varicella zoster responsive to foscarnet.
Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesviru | 1991 |
Clinical experiences with phosphonoformate (foscarnet) treatment of viral diseases following renal transplantation.
Topics: Adult; Aged; Antiviral Agents; Cytomegalovirus Infections; Female; Foscarnet; Herpes Simplex; Herpes | 1985 |